Ghent, Belgium

Sarah Gerlo

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovations of Sarah Gerlo: Pioneering Advances in Cytokine Research**

Introduction

Sarah Gerlo, an accomplished inventor based in Ghent, Belgium, has made significant strides in the field of immunology through her innovative work with cytokines. With an impressive portfolio of five patents, her inventions focus on enhancing therapeutic applications that address various diseases, including cancers.

Latest Patents

Among her latest inventions, Sarah has created a groundbreaking fusion protein that comprises at least two cytokines. Notably, at least one of these is a modified cytokine with a significantly reduced binding affinity to its receptor. This innovation, titled "Fusokines involving cytokines with strongly reduced receptor binding affinities," holds promise for treating diseases by potentially improving the efficacy and targeting of cytokine therapies.

Another significant contribution is her work on CD8 binding agents. This patent relates to agents that bind CD8, along with their use as both therapeutic and diagnostic tools. The invention includes pharmaceutical compositions that utilize these CD8 binding agents for disease treatment, particularly in oncology.

Career Highlights

Sarah's career reflects a commitment to advancing medical science through her research and inventions. She has been associated with Vib Vzw and Ghent University, where her contributions have merged academic research with practical applications, driving forward innovations in cytokine therapies.

Collaborations

Throughout her career, Sarah has collaborated with esteemed colleagues such as Jan Tavernier and Gilles Uze, further enhancing her innovative capabilities. These collaborations not only foster an environment of shared knowledge but also amplify the impact of their collective research in immunology.

Conclusion

Sarah Gerlo stands out as an influential inventor in the realm of cytokine research, with her patents pushing the boundaries of what's possible in disease treatment. Her work exemplifies the power of innovation in transforming scientific discoveries into tangible solutions that benefit society at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…